Insider Transactions in Q4 2025 at Natera, Inc. (NTRA)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 24
2025
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
755
-1.08%
|
$147,980
$196.77 P/Share
|
|
Oct 23
2025
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
495
-0.7%
|
$92,565
$187.16 P/Share
|
|
Oct 22
2025
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,250
+1.74%
|
-
|
|
Oct 22
2025
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
920
-1.31%
|
$171,120
$186.68 P/Share
|
|
Oct 21
2025
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
602
-0.85%
|
$112,574
$187.95 P/Share
|
|
Oct 21
2025
|
Steven Leonard Chapman CEO AND PRESIDENT |
SELL
Open market or private sale
|
Direct |
1,603
-1.02%
|
$299,761
$187.95 P/Share
|
|
Oct 21
2025
|
John Fesko PRESIDENT, CHIEF BUS. OFFICER |
SELL
Open market or private sale
|
Direct |
339
-0.22%
|
$63,393
$187.95 P/Share
|
|
Oct 21
2025
|
Solomon Moshkevich PRESIDENT, CLINICALDIAGNOSTICS |
SELL
Open market or private sale
|
Direct |
292
-0.25%
|
$54,604
$187.95 P/Share
|
|
Oct 21
2025
|
Daniel Rabinowitz SEC. AND CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct |
464
-0.23%
|
$86,768
$187.95 P/Share
|
|
Oct 21
2025
|
Jonathan Sheena |
SELL
Open market or private sale
|
Direct |
93
-0.04%
|
$17,391
$187.95 P/Share
|
|
Oct 20
2025
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,522
+2.11%
|
-
|
|
Oct 20
2025
|
Steven Leonard Chapman CEO AND PRESIDENT |
BUY
Exercise of conversion of derivative security
|
Direct |
3,386
+2.11%
|
-
|
|
Oct 20
2025
|
Daniel Rabinowitz SEC. AND CHIEF LEGAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
856
+0.42%
|
-
|
|
Oct 20
2025
|
Jonathan Sheena |
BUY
Exercise of conversion of derivative security
|
Direct |
190
+0.08%
|
-
|
|
Oct 20
2025
|
Matthew Rabinowitz EXECUTIVE CHAIRMAN |
SELL
Open market or private sale
|
Indirect |
10,000
-66.67%
|
$1,900,000
$190.0 P/Share
|
|
Oct 17
2025
|
Jonathan Sheena |
SELL
Open market or private sale
|
Indirect |
1,500
-1.31%
|
$267,000
$178.97 P/Share
|
|
Oct 15
2025
|
Jonathan Sheena |
SELL
Open market or private sale
|
Direct |
3,070
-0.32%
|
$537,250
$175.16 P/Share
|
|
Oct 01
2025
|
Steven Leonard Chapman CEO AND PRESIDENT |
SELL
Open market or private sale
|
Direct |
14,083
-2.14%
|
$2,253,280
$160.15 P/Share
|
|
Oct 01
2025
|
Solomon Moshkevich PRESIDENT, CLINICALDIAGNOSTICS |
SELL
Open market or private sale
|
Direct |
3,000
-0.84%
|
$477,000
$159.86 P/Share
|